Astria Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q3 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Astria Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q3 2019 to Q2 2024.
  • Astria Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $5.72M, a 765% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $5.72M +$5.05M +765% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $210K -$596K -73.9% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $363K -$585K -61.7% Dec 31, 2023 10-Q 2024-08-12
Q3 2023 $514K -$573K -52.7% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $661K -$621K -48.4% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $806K +$578K +254% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $948K +$554K +141% Dec 31, 2022 10-K 2024-03-04
Q3 2022 $1.09M +$530K +95.2% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $1.28M +$565K +78.8% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $228K -$646K -73.9% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $394K -$572K -59.2% Dec 31, 2021 10-K 2023-03-22
Q3 2021 $557K -$621K -52.7% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $717K -$609K -45.9% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $874K -$925K -51.4% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $966K -$1.38M -58.9% Dec 31, 2020 10-K 2022-03-10
Q3 2020 $1.18M +$213K +22.1% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $1.33M Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $1.8M Mar 31, 2020 10-Q 2020-05-12
Q4 2019 $2.35M Dec 31, 2019 10-K/A 2021-04-19
Q3 2019 $965K Sep 30, 2019 10-Q 2019-11-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.